Skip to content
  • For Media Professionals     Change
  • Contact Us
search bar
Janus Henderson Investors
  • About us
        • About Janus Henderson Investors

        • Our people

        • Knowledge Shared

        • Who we are
        • Our investment capabilities
        • Connecting with our clients
        • We provide access to some of the industry’s most talented and innovative thinkers.

          Meet our teams
        • Expert insight | Timely and relevant | A dialogue with our clients | Janus Henderson Investors
        • Timely and relevant expert insight for better investment and business decisions.

        • Find out more
  • Knowledge Shared
        • Knowledge Shared

        • Explore our insights

        • Global Dividend Index

        • At Janus Henderson, we believe in the sharing of expert insight for better investment and business decisions.

          We call this ethos Knowledge Shared.

        • Find out more
        • Global Perspectives
          Quarterly and monthly views on global markets and the economy.
           
        • Mega Trends
          Exploring the long-term themes reshaping the world and the impact on investors.
        • View all insights
        • Investment Viewpoints
          Updates and outlooks from our investment teams.
        • Quick Views
          Timely insights on market events.
        • It analyses dividends paid by the 1,200 largest firms by market capitalisation. It is a measure of progress that global firms are making in paying their investors an income on their capital.

          Read more

  • Insights
  • Press releases
{{banner.link_text}}
For Media Professionals

Andy Acker, CFA

Global Life Sciences | Portfolio Manager
Andy Acker, CFA | Janus Henderson Investors

Andy Acker is a Portfolio Manager at Janus Henderson Investors responsible for managing the Global Life Sciences and Biotechnology strategies since 2007 and 2018, respectively. He also leads the firm’s Health Care Sector Research Team. Andy was assistant portfolio manager on the Global Life Sciences strategy from 2003 to 2007. He joined Janus in 1999 as a research analyst focused on companies in the biotechnology and pharmaceutical industries. Prior to this, he worked as a strategy consultant for the Boston Consulting Group and as a health care analyst for Morgan Stanley Venture Partners.

Andy received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA with honours from Harvard Business School. Andy holds the Chartered Financial Analyst designation and has 25 years of financial industry experience.

Articles Written

A potential turning point in the battle against COVID-19
November 2020
Investment Viewpoints Coronavirus

A potential turning point in the battle against COVID-19

Delivering better-than-expected trial data, a vaccine candidate from Pfizer and BioNTech could mark the beginning of the end of the pandemic and boost confidence in an economic recovery, now underway.

Read More

  • Media
  • Investor relations
  • Careers
  • Contact us
  • Legal
  • Cookie policy
  • Privacy policy
  • Security information
  • LinkedIn

Privacy policy | Cookie policy

 

Cookies: The Janus Henderson Investors website uses cookies to remember your preferences and to help us to improve the site through the use of web analytics. By continuing without changing your cookie settings we will assume that you are happy to receive cookies for these two purposes. For full details on how to manage our cookies and how we use them, please see our cookie policy.

 

Please note that the media centre and links from it are solely for the use of members of the media and should not be relied upon by personal investors, financial advisers or institutional investors.

 

If you are a personal investor, financial adviser or institutional investor please visit www.janushenderson.com.

Please note that not all of the funds, products or services described on this website are available in all jurisdictions. In particular, only the US sections of this website are available to US Persons and the only investment products available to Hong Kong residents are those described under the Hong Kong section of this site. The other investment products described elsewhere on this site are not available to US or Hong Kong residents.

 

Issued in the UK by Janus Henderson Investors. Janus Henderson Investors is the name under which investment products and services are provided by Janus Capital International Limited (reg no. 3594615), Henderson Global Investors Limited (reg. no. 906355), Henderson Investment Funds Limited (reg. no. 2678531), Henderson Equity Partners Limited (reg. no.2606646), (each registered in England and Wales at 201 Bishopsgate, London EC2M 3AE and regulated by the Financial Conduct Authority) and Henderson Management S.A. (reg no. B22848 at 2 Rue de Bitbourg, L-1273, Luxembourg and regulated by the Commission de Surveillance du Secteur Financier).

 

Henderson Secretarial Services Limited (incorporated and registered in England and Wales, registered no. 1471624, registered office 201 Bishopsgate, London EC2M 3AE) is the name under which company secretarial services are provided. All these companies are wholly owned subsidiaries of Janus Henderson Group plc (incorporated and registered in Jersey, registered no. 101484, registered office 47 Esplanade, St Helier, Jersey JE1 0BD).

 

We may record telephone calls for our mutual protection, to improve customer service and for regulatory record keeping purposes.

 

Janus Henderson, Janus, Henderson, Perkins, Intech, VelocityShares, Knowledge Shared, Knowledge. Shared and Knowledge Labs are trademarks of Janus Henderson Group plc or one of its subsidiaries. © Janus Henderson Group plc.

Close Notification
You are now leaving janushenderson.com

You are now leaving our site and entering a website not operated by or affiliated with Janus Henderson Investors. While we aim to point you to useful external websites, we cannot be responsible for their content, opinions, advice or accuracy, even if you utilise the services on the linked site to invest in our products.

The protection of your personal information on other websites is not governed by Janus Henderson Investors privacy policy and Janus Henderson Investors cannot be responsible for the privacy policies utilised on such third party sites, nor for the implementation of such policies by those third parties.

You should review the Terms and Conditions of third party websites and contact the operators of such sites if you have any queries.

You are now leaving Janus Henderson's website and will be redirected to the website of the Securities and Exchange Commission (the "SEC"). Money market funds are required to provide the SEC with a monthly electronic filing of more detailed portfolio holdings information on Form N-MFP.

Janus Henderson is not responsible for the content, accuracy or timeliness and does not make any warranties, express or implied, with regard to the information obtained from other websites. This link should not be construed as either a recommendation or offer to by or sell any securities.

Region

Country

Language

What type of investor are you?